JPWO2019197609A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019197609A5
JPWO2019197609A5 JP2020555884A JP2020555884A JPWO2019197609A5 JP WO2019197609 A5 JPWO2019197609 A5 JP WO2019197609A5 JP 2020555884 A JP2020555884 A JP 2020555884A JP 2020555884 A JP2020555884 A JP 2020555884A JP WO2019197609 A5 JPWO2019197609 A5 JP WO2019197609A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding portion
seq
bst1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020555884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021521201A (ja
Publication date
Priority claimed from GBGB1806084.8A external-priority patent/GB201806084D0/en
Application filed filed Critical
Publication of JP2021521201A publication Critical patent/JP2021521201A/ja
Publication of JPWO2019197609A5 publication Critical patent/JPWO2019197609A5/ja
Withdrawn legal-status Critical Current

Links

JP2020555884A 2018-04-13 2019-04-12 骨髄異形成症候群を予防または治療するためのｂｓｔ１に対する抗体 Withdrawn JP2021521201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1806084.8A GB201806084D0 (en) 2018-04-13 2018-04-13 Antibodies
GB1806084.8 2018-04-13
PCT/EP2019/059420 WO2019197609A1 (en) 2018-04-13 2019-04-12 Antibodies against bst1 for preventing or treating myelodysplastic syndrome

Publications (2)

Publication Number Publication Date
JP2021521201A JP2021521201A (ja) 2021-08-26
JPWO2019197609A5 true JPWO2019197609A5 (hr) 2022-04-19

Family

ID=62203296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020555884A Withdrawn JP2021521201A (ja) 2018-04-13 2019-04-12 骨髄異形成症候群を予防または治療するためのｂｓｔ１に対する抗体

Country Status (7)

Country Link
US (1) US20210032360A1 (hr)
EP (1) EP3773917A1 (hr)
JP (1) JP2021521201A (hr)
CN (1) CN111971091A (hr)
GB (1) GB201806084D0 (hr)
TW (1) TW201943732A (hr)
WO (1) WO2019197609A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201711785D0 (en) * 2017-07-21 2017-09-06 Berlin-Chemie Ag Antibodies
CN112630438B (zh) * 2021-03-08 2021-06-22 信纳克(北京)生化标志物检测医学研究有限责任公司 抗体组合物及其筛查髓系疾病及检测免疫检查点的应用
WO2024020051A1 (en) * 2022-07-19 2024-01-25 BioLegend, Inc. Anti-cd157 antibodies, antigen-binding fragments thereof and compositions and methods for making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005295921A (ja) * 2004-04-14 2005-10-27 Pharma Design Inc 新規ｂｓｔ１選択的スプライシング変異体及びその用途
UA112062C2 (uk) * 2010-10-04 2016-07-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Cd33-зв'язувальний агент
EP2726508B1 (en) * 2011-06-28 2017-08-09 Oxford BioTherapeutics Ltd Antibodies to adp-ribosyl cyclase 2

Similar Documents

Publication Publication Date Title
US20210024635A1 (en) Anti-wt1/hla-specific antibodies
JP2019532056A5 (hr)
RU2019111722A (ru) Антитела против siglec-15 и способы их применения
JP2013534809A5 (hr)
JP2008529497A5 (hr)
RU2010132956A (ru) Ангиопоэтин-2-специфические связывающие агенты
RU2010119450A (ru) Антитело против bst2
RU2012103212A (ru) Tlr3 связывающие агенты
JP2020514277A5 (hr)
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2024024114A5 (hr)
JPWO2019175223A5 (hr)
CN112888458A (zh) Cldn18的抗体和化疗药物的联合治疗
RU2019121106A (ru) Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1)
JP2020513759A5 (hr)
JP2023133432A5 (hr)
JP2020522280A5 (hr)
JP2020522281A5 (hr)
JPWO2019224711A5 (hr)
CN116396386A (zh) Cd3抗体及其药物用途
WO2022105914A1 (zh) Cd70抗体及其应用
JPWO2019223733A5 (hr)
JPWO2019197609A5 (hr)
RU2020128108A (ru) Антитело против cd25 для опухоль-специфической клеточной деплеции
JPWO2019212965A5 (hr)